Snowden Capital Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-463
Closed -$42K 1957
2021
Q4
$42K Buy
+463
New +$55.3K ﹤0.01% 1088
2021
Q2
Sell
-1,517
Closed -$276K 900
2021
Q1
$276K Sell
1,517
-19
-1% -$4.41K 0.02% 657
2020
Q4
$307K Buy
+1,536
New +$312K 0.02% 524

Other funds holding TDOC

Snowden Capital Advisors's TDOC Position: Q1 2022 in Review

Snowden Capital Advisors sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 463 shares — an estimated $42K sold.

Snowden Capital Advisors first reported a position in TDOC in Q4 2020 and held it in 3 quarters. The position peaked at $307K in Q4 2020. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Snowden Capital Advisors reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Snowden Capital Advisors sold 463 Teladoc Health shares in Q1 2022, an estimated $42K.
  • Snowden Capital Advisors first reported a position in Teladoc Health in Q4 2020 and held it in 3 quarters.
  • Snowden Capital Advisors's Teladoc Health position peaked at $307K in Q4 2020.
  • 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Snowden Capital Advisors's 13F filing for Q1 2022, filed 16 May 2022.